• BIO 2018

Connecting Industry with African Leaders to Improve Cancer Care

The African Access Initiative (AAI) is a partnership of companies, governments, healthcare providers, and NGOs focused on sustainably expanding access to cancer medicines and technologies, improving healthcare infrastructure, and building clinical and R&D capacity in Africa.

Unique features:
‌•  Driven by self-identified needs of each country and hospital
‌•  Tailored access agreements align needs with companies’ assets to deliver medications and technologies
‌•  Companies’ clinical and R&D instrumentation placed in hospitals and laboratories
‌•  Fellowships support knowledge exchange among companies, NGOs, and African oncologists and researchers

Cancer causes 60% more deaths in Africa than malaria

Learn more about the African Access Initiative and hear from our partners:

BVGH's Approach

African Access Initiative

Cancer is Deadlier than Malaria

60% more Africans die from cancer than malaria, and the number of cancer deaths is expected to increase almost 70% by 2030. BVGH and partners released a white paper on the African continent's emerging cancer crisis.

“As a researcher dedicated to unraveling breast cancer genetics in women of African descent, and as a native of Nigeria, I understand cancer’s toll in Africa from both scientific and personal perspectives. I am thrilled to partner with BVGH and AAI to empower African healthcare providers to better prevent, diagnose, and treat cancer across the continent.”

Dr. Olufunmilayo (Funmi) Olopade, University of Chicago, IL, USA

Learn more from BVGH President Jennifer Dent at the 2017 BIO International Convention:

Our Partners

Learn More

To learn more about the African Access Initiative, contact Danielle Matia